Publications by authors named "Vladislava O Melnikova"

26Publications

Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.

Proc Natl Acad Sci U S A 2011 Jan 27;108(2):626-31. Epub 2010 Dec 27.

Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1006886108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021062PMC
January 2011

CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.

PLoS One 2010 Aug 27;5(8):e12452. Epub 2010 Aug 27.

Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012452PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929203PMC
August 2010

Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.

J Biol Chem 2009 Sep 24;284(38):26194-206. Epub 2009 Jul 24.

Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M109.019836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758018PMC
September 2009

Inflammation and melanoma metastasis.

Pigment Cell Melanoma Res 2009 Jun 8;22(3):257-67. Epub 2009 Apr 8.

Department of Cancer Biology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1755-148X.2009.00570.xDOI Listing
June 2009

Emerging roles of PAR-1 and PAFR in melanoma metastasis.

Cancer Microenviron 2008 Dec 20;1(1):103-11. Epub 2008 Feb 20.

Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12307-008-0002-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654348PMC
December 2008

Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.

Am J Pathol 2008 Dec 6;173(6):1839-52. Epub 2008 Nov 6.

Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/ajpath.2008.080380DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626394PMC
December 2008

Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape.

Am J Clin Dermatol 2008 ;9(5):307-11

Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00128071-200809050-00004DOI Listing
January 2009

Searching for the Achilles' heel of melanoma cells: new treatment modalities.

Pigment Cell Melanoma Res 2008 Oct 15;21(5):505-6. Epub 2007 Aug 15.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1755-148X.2008.00493.xDOI Listing
October 2008

Transcriptional control of the melanoma malignant phenotype.

Cancer Biol Ther 2008 Jul 30;7(7):997-1003. Epub 2008 Jun 30.

Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.7.7.6535DOI Listing
July 2008

P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer.

Adv Exp Med Biol 2008 ;624:265-82

Department of Immunology, The University of Texas M.D. Anderson Cancer Center, P.O. Box 301402, Unit #902, Houston, TX 77030-1903, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-77574-6_21DOI Listing
April 2008

Models and mechanisms in malignant melanoma.

Mol Carcinog 2007 Aug;46(8):671-8

Department of Immunology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.20353DOI Listing
August 2007

ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis.

Cancer Res 2007 Jun;67(11):5258-66

The Institute of Biochemistry, Food Science, and Nutrition, Faculty of Agricultural, Food, and Environmental Quality Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-0129DOI Listing
June 2007

Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8.

Pigment Cell Res 2006 Oct;19(5):395-405

Department of Cancer Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0749.2006.00331.xDOI Listing
October 2006

Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.

J Biol Chem 2006 Feb 23;281(5):2911-22. Epub 2005 Nov 23.

Department of Cancer Biology, the University of Texas M. D. Anderson Cancer Center and the Program in Cancer Biology, the University of Texas Graduate School of Biomedical Sciences, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M508683200DOI Listing
February 2006

Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development.

Oncogene 2005 Oct;24(47):7055-63

Department of Immunology, The University of Texas MD Anderson Cancer Center, PO Box 301402, Unit 902, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208863DOI Listing
October 2005

Cellular and molecular events leading to the development of skin cancer.

Mutat Res 2005 Apr;571(1-2):91-106

Department of Immunology, The University of Texas M.D. Anderson Cancer Center, P.O. Box 301402, Unit 902, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mrfmmm.2004.11.015DOI Listing
April 2005

Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines.

Oncogene 2004 Mar;23(13):2347-56

Department of Immunology, The University of Texas MD Anderson Cancer Center, PO Box 301402, Unit 902, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207405DOI Listing
March 2004

Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase.

Oncogene 2003 Sep;22(38):5958-66

Department of Immunology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 178, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206595DOI Listing
September 2003